Effects of direct- and indirect-acting serotonin receptor agonists on the antinociceptive and discriminative stimulus effects of morphine in rhesus monkeys

Neuropsychopharmacology

Volumn 36, Issue 5, 2011, Pages 940-949

  Li, Jun Xu ^a   Koek, Wouter ^a   Rice, Kenner C ^b   France, Charles P ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

antinociception; drug discrimination; drug interaction; morphine; rhesus monkey; serotonin

Indexed keywords

2 C T 7; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,5 DIMETHOXY 4 METHYLAMPHETAMINE; 2,5 DIMETHOXY 4 N PROPYLTHIOPHENETHYLAMINE; 3 CHLORO 4 FLUOROPHENYL [4 FLUORO 4 [[(5 METHYL 6 METHYLAMINOPYRIDIN 2 YLMETHYL)AMINO]METHYL]PIPERIDIN 1 YL]METHANONE FUMARIC ACID SALT; BUSPIRONE; DIRECT ACTING SEROTONIN RECEPTOR AGONIST; F 13714; FENFLURAMINE; INDIRECT ACTING SEROTONIN RECEPTOR AGONIST; MORPHINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; QUIPAZINE; SEROTONIN AGONIST; UNCLASSIFIED DRUG; VOLINANSERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; FEMALE; LATENT PERIOD; MALE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG INTERACTIONS; FENFLURAMINE; FLUOROBENZENES; HOT TEMPERATURE; HUMANS; HYPERALGESIA; MACACA MULATTA; MALE; MORPHINE; NARCOTICS; PAIN THRESHOLD; PIPERIDINES; REACTION TIME; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 79952770129     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.232     Document Type: Article

References (22)

1. Banks ML, Rice KC, Negus SS (2010). Antinociceptive interactions between mu-opioid receptor agonists and the serotonin uptake inhibitor clomipramine in rhesus monkeys: role of my agonist efficacy. J Pharmacol Exp Ther 335: 497-505.
2. Coda BA, Hill HF, Schaffer RL, Luger TJ, Jacobson RC, Chapman CR (1993). Enhancement of morphine analgesia by fenfluramine in subjects receiving tailored opioid infusions. Pain 52: 85-91. (Pubitemid 23036036)
3. Crisp T, Stafinsky JL, Spanos LJ, Uram M, Perni VC, Donepudi HB (1991). Analgesic effects of serotonin and receptor-selective serotonin agonists in the rat spinal cord. Gen Pharmacol 22: 247-251.
4. Fasmer OB, Berge OG, Post C, Hole K (1986). Effects of the putative 5-HT1A receptor agonist 8-OH-2-(di-n-propylamino)tetralin on nociceptive sensitivity in mice. Pharmacol Biochem Behav 25: 883-888. (Pubitemid 17179909)
5. Gatch MB, Negus SS, Mello NK (1998). Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys. Psychopharmacology 135: 99-106. (Pubitemid 28055455)
6. Gutstein H, Akil H (2005). Opioid analgesics. In: Brunton L, Lazo J, Parker K (eds). The Pharmacological Basis of Therapeutics 11th edn. McGraw-Hill: New York. pp 547-590.
7. Higgins GA, Wang Y, Sellers EM (1993). Preliminary findings with the indirect 5-HT agonist dexfenfluramine on heroin discrimination and self-administration in rats. Pharmacol Biochem Behav 45: 963-966.
8. Hynes MD, Lochner MA, Bemis KG, Hymson DL (1985). Fluoxetine, a selective inhibitor of serotonin uptake, potentiates morphine analgesia without altering its discriminative stimulus properties or affinity for opioid receptors. Life Sci 36: 2317-2323. (Pubitemid 15066041)
9. 1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential. Eur J Pharmacol 420: 103-112. (Pubitemid 32537684)
10. Larson AA, Takemori AE (1977). Effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake, on morphine analgesia and the development of tolerance. Life Sci 21: 1807-1812.
11. Li JX, Becker GL, Traynor JR, Gong ZH, France CP (2007). Thienorphine: receptor binding and behavioral effects in rhesus monkeys. J Pharmacol Exp Ther 321: 227-236. (Pubitemid 46456954)
12. Li JX, McMahon LR, Gerak LR, Becker GL, France CP (2008). Interactions between delta (9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception. Psychopharmacology 199: 199-208.
13. 2A receptor agonist 1-(2,5-dimethoxy-4- methylphenyl)-2-aminopropane in rats and rhesus monkeys. J Pharmacol Exp Ther 333: 244-252.
14. Malmberg AB, Yaksh TL (1993). Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 79: 270-281. (Pubitemid 23224839)
15. Manchikanti L (2007). National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician 10: 399-424. (Pubitemid 46971294)
16. 2 receptor subtypes. Behav Neurosci 117: 212-221. (Pubitemid 36384240)
17. 1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner. J Pharmacol Exp Ther 256: 983-992.
18. Miranda HF, Puig MM, Dursteler C, Prieto JC, Pinardi G (2007). Dexketoprofen-induced antinociception in animal models of acute pain: synergy with morphine and paracetamol. Neuropharmacology 52: 291-296. (Pubitemid 46137971)
19. National Research Council (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press: Washington, DC.
20. Schuster CR, Johanson CE (1988). Relationship between the discriminative stimulus properties and subjective effects of drugs. Psychopharmacol Ser 4: 161-175.
21. [11C]labeled PET ligands. Bioorg Med Chem 8: 2427-2432.
22. Xu W, Qiu XC, Han JS (1994). Serotonin receptor subtypes in spinal antinociception in the rat. J Pharmacol Exp Ther 269: 1182-1189. (Pubitemid 24204203)